SpaceX IPO is the biggest IPO in stock market history. Join the conversation.Click here

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksMcbride Regulatory News (MCB)

Share Price Information for Mcbride (MCB)

Share Price is delayed by 15 minutes
Get Live Data
141.60    -24.20 (-14.60%)
Bid:
140.20
Ask:
144.80
Spread: 4.60 (3.281%)
Market Cap: £241.94m
MCB Live PriceLast checked at - London Stock Exchange

Intraday Mcbride Share Chart

Replacement: Directorate Change

9 Jul 2021 13:27

RNS Number : 7953E
McBride PLC
09 July 2021
 

The following amendment has been made to the 'Directorate Change' announcement released on 9 July 2021 at 10:32 under RNS No 7586E.

 

The following paragraph was amended from:

 

"Alastair is an independent member of the Department for Education. He currently holds no other directorships, however until September 2019 he was a director and Chief Financial Officer of Premier Foods plc."

 

to

 

"Alastair is an independent member of the Audit and Risk Committee at the Department for Education. He currently holds no other directorships, however, until August 2019 he was a director and Chief Financial Officer of Premier Foods plc."

 

All other details remain unchanged.

 

The full amended text is shown below.

 

 

9 July 2021

 

McBride plc

 

Directorate change

 

McBride plc ("McBride" or the "Company") announces the appointment of Alastair Murray as a Non-Executive Director with effect from 2 August 2021.

 

Neil Harrington, Chair of the Audit Committee will be stepping down from the Board at the 2021 annual general meeting ("AGM"). As part of the Company's succession plans, it has been agreed that Alastair will be appointed as Chair of the Audit Committee immediately following the AGM. His appointment to Chair of the Audit Committee will be subject to his appointment as a director at the AGM.

 

Alastair has recent and relevant financial experience across a number of listed companies, including Premier Foods plc, Dairy Crest plc and The Body Shop International plc. As well as a background in Finance, Alastair has significant experience in corporate strategy, restructuring and M&A.

 

Alastair is an independent member of the Audit and Risk Committee at the Department for Education. He currently holds no other directorships, however, until August 2019 he was a director and Chief Financial Officer of Premier Foods plc.

 

Alastair will become a member of the Nomination, Remuneration and Audit Committees.

 

Jeff Nodland, Chairman of McBride, said: "Alastair brings valuable experience from customer-focused businesses including The Body Shop and Premier Foods. This, combined with his strong financial experience makes him an excellent addition to the Board. We are delighted to welcome Alastair to McBride."

 

McBride has been notified that there are no further details to be disclosed in respect of Alastair Murray pursuant to Rule 9.6.13 of the Listing Rules of the UK Listing Authority.

 

 

McBride plc

 

Jeff Nodland, Chairman

0161 203 7570

Chris Smith, CEO

 

 

 

FTI Consulting

 

Ed Bridges, Nick Hasell

020 3727 1017

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
BOADKCBBBBKDAOK
Date   Source Headline
12th Jun 20267:00 amRNSTrading and Acquisition Update
11th Jun 20261:44 pmRNSDirector/PDMR Shareholding
2nd Jun 20267:00 amRNSTransaction in Own Shares
27th May 20267:00 amRNSTransaction in Own Shares
19th May 20267:00 amRNSTransaction in Own Shares
12th May 20267:00 amRNSTransaction in Own Shares
6th May 20267:00 amRNSTransaction in Own Shares
1st May 20267:00 amRNSSecond tranche of share buyback programme
1st May 20267:00 amRNSTransaction in Own Shares
29th Apr 20267:00 amRNSTransaction in Own Shares
28th Apr 20267:00 amRNSTransaction in Own Shares
21st Apr 20267:00 amRNSTransaction in Own Shares
20th Apr 20267:00 amRNSTransaction in Own Shares
16th Apr 20267:00 amRNSTransaction in Own Shares
15th Apr 20267:00 amRNSTransaction in Own Shares
7th Apr 20267:00 amRNSTransaction in Own Shares
2nd Apr 20267:00 amRNSTransaction in Own Shares
2nd Apr 20267:00 amRNSProposed Acquisition & Trading Conditions Update
1st Apr 20267:00 amRNSTransaction in Own Shares
31st Mar 20267:00 amRNSTransaction in Own Shares
30th Mar 20267:00 amRNSTransaction in Own Shares
27th Mar 20267:00 amRNSTransaction in Own Shares
26th Mar 20267:00 amRNSTransaction in Own Shares
25th Mar 20267:00 amRNSTransaction in Own Shares
24th Mar 20267:00 amRNSTransaction in Own Shares
23rd Mar 20267:00 amRNSTransaction in Own Shares
20th Mar 20267:00 amRNSTransaction in Own Shares
19th Mar 20267:00 amRNSTransaction in Own Shares
18th Mar 20267:00 amRNSTransaction in Own Shares
17th Mar 20267:00 amRNSTransaction in Own Shares
17th Mar 20267:00 amRNSTransaction in Own Shares
16th Mar 20267:00 amRNSTransaction in Own Shares
16th Mar 20267:00 amRNSTransaction in Own Shares
13th Mar 20267:00 amRNSTransaction in Own Shares
13th Mar 20267:00 amRNSTransaction in Own Shares
12th Mar 20267:00 amRNSTransaction in Own Shares
11th Mar 20267:00 amRNSTransaction in Own Shares
10th Mar 20267:00 amRNSDirector Appointment
10th Mar 20267:00 amRNSTransaction in Own Shares
10th Mar 20267:00 amRNSTransaction in Own Shares
9th Mar 20267:00 amRNSTransaction in Own Shares
6th Mar 20267:00 amRNSTransaction in Own Shares
5th Mar 20267:00 amRNSTransaction in Own Shares
4th Mar 20267:00 amRNSTransaction in Own Shares
3rd Mar 20267:00 amRNSTransaction in Own Shares
2nd Mar 20267:00 amRNSTransaction in Own Shares
27th Feb 20266:28 pmRNSDirectorate change
27th Feb 20267:00 amRNSTransaction in Own Shares
26th Feb 20267:00 amRNSTransaction in Own Shares
24th Feb 20267:05 amRNSInterim results for 6M ended 31 December 2025

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.